Resource Library

SoWMy cover

The State of the World’s Midwifery 2021

UNFPA, ICM, WHO, 2021

The State of the World’s Midwifery (SoWMy) 2021 presents findings on the Sexual, Reproductive, Maternal, Newborn and Adolescent Health (SRMNAH) workforce from 194 countries. The report, produced by UNFPA, the International Confederation of Midwives (ICM), the World Health Organization (WHO) and Novametrics, shows the progress and trends since the inaugural 2011 edition and identifies the barriers and challenges to future advancement. The report establishes a global shortage of 1.1 million SRMNAH workers, the largest shortage (900,000) being midwives. It calls for urgent investment in midwives to enable them to fulfil their potential to contribute towards UHC and the SDG agenda.

Midwives

Global Midwives' Hub

International Confederation of Midwives, 2021

The Global Midwives' Hub is an online resource that allows for knowledge sharing between users, data visualization tools and improved data literacy to support midwives advocate for the midwifery profession in their country and/or region. 

Fact sheet - COVID-19

Fact Sheet: COVID-19 Infection & Deaths Among Nurses and Other Health Care Workers

International Council of Nurses (ICN), 2021

This International Council of Nurses (ICN) fact sheet highlights COVID-19's impact on nurses and other health care workers ahead of International Nurses Day 2021.

IND fact sheet - nursing stress

Fact Sheet: Stress & Burnout in the Nursing Profession

International Council of Nurses (ICN), 2021

This International Council of Nurses (ICN) fact sheet highlights stress and burnout in the nursing profession ahead of International Nurses Day 2021.

IND fact sheet

Fact Sheet: Nurse Shortage and Retention

International Council of Nurses (ICN), 2021

This International Council of Nurses (ICN) fact sheet highlights global nurse shortages and retention issues ahead of International Nurses Day 2021.

NGOConnect

NGOConnect

FHI360, 2021

Resources and knowledge sharing for connecting and strengthening civil society organizations (CSOs), networks, and support organizations worldwide.

RRHO success story

Success Story: LBNM Launches New Policies and Strengthens Capacity through HRSA-funded RRHO Project Partner Engagement

Resilient & Responsive Health Organizations (RRHO), 2021

The Resilient and Responsive Health Organizations (RRHO) project builds the capacity of diverse institutions or “impact partners” that include schools of medicine, midwifery and nursing, professional associations, and government ministries that contribute to improving the quality of health professional education in Liberia, Sierra Leone, and the Democratic Republic of Congo. This RRHO success story describes RRHO's capacity development approach and support to the Liberian Board for Nursing and Midwifery (LBNM). 

TPT FAQ

Frequently Asked Questions on TB preventive treatment (TPT)

World Health Organization (WHO), 2020

Tuberculosis (TB) preventive treatment (or TPT) consists of a course of one or more anti-tuberculosis medicines given with the intention of preventing the development of TB disease. TPT is only given to people who are infected with TB bacteria or have been exposed to it and are at a higher risk of developing TB disease than the general population. TPT is considered one of the most critical public health measures to protect both individuals and the community from TB. These frequently asked questions on TPT are associated with the WHO Consolidated Guidelines on TB - TB Preventive Treatment (2020).

WHO TPT

WHO consolidated guidelines on TB - TB preventive treatment (TPT)

World Health Organization (WHO), 2020

About one fourth of the world’s population is estimated to be infected with the tuberculosis (TB) bacterium, and about 5–10% of those infected develop active TB disease in their lifetime. The risk for active TB disease after infection depends on several factors, the most important being the person’s immunological status. The 18 recommendations on tuberculosis preventive treatment in the 2020 update cover critical steps in programmatic management that follow the cascade of preventive care. The main changes introduced include conditional recommendations for a 1-month daily rifapentine and isoniazid regimen and a 4-month daily rifampicin regimen as alternative treatment options in all TB burden settings. Advice on isoniazid preventive treatment in pregnancy and on the concomitant use of rifapentine and dolutegravir has been updated to reflect the findings from latest studies. The operational limitations that need to be overcome by countries to achieve global targets are highlighted and will be discussed in greater detail in the accompanying operational handbook that is being released concurrently. The guidelines are to be used primarily in national TB and HIV programmes, or their equivalents in ministries of health, and for other policy-makers working on TB and HIV and infectious diseases in public and private sectors and in the community.

MMD poster

Rapid Adaptation of HIV DSD Program Design in Response to COVID-19: Results from 14 Countries in Sub-Saharan Africa

ICAP, 2020

As the COVID-19 pandemic spread to Africa, CQUIN network countries made significant policy modifications to their differentiated service delivery (DSD) models to protect recipients of care and health care workers and to enhance program resilience.  The most common adaptation was the expansion of multi-month dispensing (MMD) to decrease health facility visit frequency. Ten countries expanded MMD eligibility, including four that waived requirements for HIV viral load suppression for people on ART, six that newly permitted MMD for people initiating antiretroviral therapy (ART). This poster describes rapid adaptation of HIV differentiated service delivery program design in response to COVID-19: results from 14 countries in sub-Saharan Africa.